Cable Hill Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-38
Closed -$6K 810
2019
Q1
$6K Hold
38
﹤0.01% 591
2018
Q4
$5K Hold
38
﹤0.01% 585
2018
Q3
$7K Sell
38
-170
-82% -$31.2K ﹤0.01% 505
2018
Q2
$35K Hold
208
0.01% 243
2018
Q1
$34K Sell
208
-36
-15% -$6.04K 0.01% 253
2017
Q4
$42K Sell
244
-271
-53% -$48.6K 0.02% 262
2017
Q3
$106K Buy
515
+370
+255% +$86K 0.05% 151
2017
Q2
$35K Hold
145
0.02% 185
2017
Q1
$35K Buy
145
+86
+146% +$20K 0.02% 188
2016
Q4
$12K Hold
59
0.01% 375
2016
Q3
$14K Buy
59
+8
+16% +$1.96K 0.01% 354
2016
Q2
$12K Buy
51
+13
+34% +$3K 0.01% 343
2016
Q1
$11K Sell
38
-32
-46% -$9.16K 0.01% 342
2015
Q4
$22K Hold
70
0.02% 233
2015
Q3
$20K Sell
70
-28
-29% -$8.6K 0.02% 255
2015
Q2
$31K Buy
98
+9
+10% +$2.68K 0.02% 214
2015
Q1
$26K Hold
89
0.02% 231
2014
Q4
$23K Buy
+89
New +$22.2K 0.02% 266

Other funds holding AGN

Cable Hill Partners's AGN Position: Q2 2019 in Review

Cable Hill Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 38 shares — an estimated $6K sold.

Cable Hill Partners first reported a position in AGN in Q4 2014 and held it in 18 quarters. The position peaked at $106K in Q3 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Cable Hill Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 38 Allergan plc shares in Q2 2019, an estimated $6K.
  • Cable Hill Partners first reported a position in Allergan plc in Q4 2014 and held it in 18 quarters.
  • Cable Hill Partners's Allergan plc position peaked at $106K in Q3 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.